Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Paulina Lange"'
Autor:
Filipa Lynce, Laura E. Stevens, Zheqi Li, Jane E. Brock, Anushree Gulvady, Ying Huang, Faina Nakhlis, Ashka Patel, Jeremy M. Force, Tufia C. Haddad, Naoto Ueno, Vered Stearns, Antonio C. Wolff, Amy S. Clark, Jennifer R. Bellon, Edward T. Richardson, Justin M. Balko, Ian E. Krop, Eric P. Winer, Paulina Lange, E. Shelley Hwang, Tari A. King, Sara M. Tolaney, Alastair Thompson, Gaorav P. Gupta, Elizabeth A. Mittendorf, Meredith M. Regan, Beth Overmoyer, Kornelia Polyak
Publikováno v:
Breast Cancer Research, Vol 26, Iss 1, Pp 1-14 (2024)
Abstract Background Patients with inflammatory breast cancer (IBC) have overall poor clinical outcomes, with triple-negative IBC (TN-IBC) being associated with the worst survival, warranting the investigation of novel therapies. Preclinical studies i
Externí odkaz:
https://doaj.org/article/f555191ada5c4d40b9318904da4ff97d
Autor:
Ana C Garrido-Castro, Noah Graham, Kevin Bi, Jihye Park, Jingxin Fu, Tanya Keenan, Edward Thomas Richardson, Ricardo Pastorello, Paulina Lange, Victoria Attaya, Robert Wesolowski, Natalie Sinclair, Zarah Lucas, Steve Lo, Nadine Tung, Meredith Faggen, Peter A Kaufman, Caroline C Block, Fred Briccetti, Madhavi Toke, Wendy Chen, Kai Wucherpfennig, Sascha Marx, Ye Tian, Judith Agudo, Jennifer L Guerriero, Stuart Schnitt, Nancy U Lin, Eric P Winer, Elizabeth A Mittendorf, Nabihah Tayob, Eliezer Van Allen, Sara M Tolaney
Publikováno v:
Cancer Research. 82:P2-14
Background: Platinum agents induce DNA crosslinking and cause accumulation of genotoxic stress, which leads to immune activation via IFN-γ signaling, making the combination with nivolumab (PD-1 antibody) an attractive strategy to enhance the benefit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab06b6799048f3fc518e72aa6d5cdcb6
https://doi.org/10.1158/1538-7445.sabcs21-p2-14-18
https://doi.org/10.1158/1538-7445.sabcs21-p2-14-18
Autor:
Romualdo Barroso-Sousa, Tianyu Li, Sangeetha Reddy, Leisha A. Emens, Beth Overmoyer, Paulina Lange, Molly K Dilullo, Victoria Attaya, Jeffrey Kimmel, Eric P. Winer, Elizabeth A. Mittendorf, Nabihah Tayob, Sara M. Tolaney
Publikováno v:
Cancer Research. 82:GS2-10
Background: While high tumor mutational burden (TMB-H) has been used as a tissue-agnostic biomarker for approval of immune checkpoint inhibitors (ICI), there is a paucity of data regarding efficacy of ICI in TMB-H MBC. The aim of this study was to ev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b38f5c033470bc5614a266562b166c57
https://doi.org/10.1158/1538-7445.sabcs21-gs2-10
https://doi.org/10.1158/1538-7445.sabcs21-gs2-10
Autor:
Ferras Alashkar, Hannes Klump, Cara Paulina Lange, Pia Proske, Maximilian Schüssler, Raina Yamamoto, Alexander Carpinteiro, Christoph Alexander Berliner, Thomas Wilfried Schlosser, Alexander Röth, Hans Christian Reinhardt
Publikováno v:
European journal of haematologyREFERENCES. 109(6)
Paravertebral extramedullary hematopoietic masses (EHMs) account for up to 15% of extramedullary pseudotumors in beta-thalassemia (BT) and are most likely related to compensatory hematopoiesis. In most cases, pseudotumors are incidentally detected, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ff9ea0c4d14ee6d524a38c331f9e3b4
https://pubmed.ncbi.nlm.nih.gov/36045599
https://pubmed.ncbi.nlm.nih.gov/36045599
Autor:
Catherine Parker, Priscilla F. McAuliffe, Katherina Zabicki Calvillo, Kristalyn K. Gallagher, Shawna C. Willey, Laura H. Rosenberger, Faina Nakhlis, Stephen DeSantis, Kandice K. Ludwig, Lisa K. Jacobs, Sheldon Feldman, Stuart J. Schnitt, Paulina Lange, Rebecca Gelman, Tari A. King, Gabrielle M. Baker, Melissa Pilewskie
Publikováno v:
Annals of Surgical Oncology. 28:2573-2578
Available retrospective data suggest the upgrade rate for intraductal papilloma (IP) without atypia on core biopsy (CB) ranges from 0 to 12%, leading to variation in recommendations. We conducted a prospective multi-institutional trial (TBCRC 034) to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c9e10f63b4f655d3f5352d76962f69a8
https://doi.org/10.1245/s10434-020-09215-w
https://doi.org/10.1245/s10434-020-09215-w
Autor:
Faina, Nakhlis, Gabrielle M, Baker, Melissa, Pilewskie, Rebecca, Gelman, Katherina Z, Calvillo, Kandice, Ludwig, Priscilla F, McAuliffe, Shawna, Willey, Laura H, Rosenberger, Catherine, Parker, Kristalyn, Gallagher, Lisa, Jacobs, Sheldon, Feldman, Paulina, Lange, Stephen D, DeSantis, Stuart J, Schnitt, Tari A, King
Publikováno v:
Annals of surgical oncology. 28(5)
Available retrospective data suggest the upgrade rate for intraductal papilloma (IP) without atypia on core biopsy (CB) ranges from 0 to 12%, leading to variation in recommendations. We conducted a prospective multi-institutional trial (TBCRC 034) to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::afd5227ef280ce77352e69653c58da49
https://pubmed.ncbi.nlm.nih.gov/33047246
https://pubmed.ncbi.nlm.nih.gov/33047246